Lynx1 Capital Management LP: AGIOS PHARMACEUTICALS INC (AGIO): Quarterly 13F Position History
As of Q1 2026, Lynx1 Capital Management LP reported 2,611,568 shares of AGIOS PHARMACEUTICALS INC (AGIO), worth $88.3M and representing 14.0% of its 13F equity book. Quarter-over-quarter share count change: + 2,531,944 (+3179.9%) . The position first appeared in Q4 2025 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 2,611,568Shares Held (Latest Filing)
- $88.3MReported Market Value (Latest Filing)
- 14.0%Portfolio Weight (% of 13F Equity Book)
- +2,531,944Quarter-over-Quarter Share Change
- +$86.2MQuarter-over-Quarter Value Change
- 2,611,568Peak Reported Shares (Historical)
Recent initiation: Lynx1 Capital Management LP first reported AGIO on the Q4 2025 filing — fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 2,611,568 | +2,531,944 | +3179.9% | $88.3M | 14.0% | $33.8 |
| Q4 2025 | 79,624 | — | — | $2.2M | 0.4% | $27.2 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Lynx1 Capital Management LP first disclose a AGIO position in 13F-HR filings?
Lynx1 Capital Management LP first reported AGIOS PHARMACEUTICALS INC (AGIO) on its 13F-HR filing for the period ending 2025-12-31 (Q4 2025). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Lynx1 Capital Management LP's most recent quarter-over-quarter share-count change in AGIO?
Between Q4 2025 and Q1 2026, Lynx1 Capital Management LP added 2,531,944 shares of AGIO (+3179.9%), bringing the total reported position to 2,611,568 shares at a market value of $88.3M.
Does the implied price-per-share represent Lynx1 Capital Management LP's cost basis in AGIO?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.